Int. J. Mol. Sci., 2022 · DOI: 10.3390/ijms232213833 · Published: November 10, 2022
Spinal cord injury (SCI) disrupts motor, sensory, and autonomic functions, affecting thousands of individuals globally each year. Despite extensive research, effective therapies are lacking due to the complex pathophysiology of SCI, hindering functional repair and regeneration. Recent studies have begun to uncover the intricate mechanisms involved in SCI, leading to the development of new therapeutic approaches. These strategies aim to modulate secondary injury events, promote neuroprotection, and facilitate neuroregeneration for functional recovery. A successful therapy might target different pathologic events to control the progression of secondary damage of SCI and promote regeneration leading to functional recovery.
Early surgical decompression (within 24 hours) is recommended for traumatic cervical SCI patients to improve neurological recovery.
Targeting specific secondary injury events, such as vascular alterations, excitotoxicity, metabolic imbalances, and inflammation, holds promise for neuroprotection and neuroregeneration.
Combining molecular approaches with cell therapy, biomaterials, and/or epidural electrical stimulation may be a successful strategy to tackle different events and enhance functional recovery.